1 active trials 1 recruiting 3 disease areas
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT07249346 | Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib… | Leukemia | Recruiting | 2026-09-02 |
Leukemia (1) · MDS/MPN Overlap (1) · Myelodysplastic Syndromes (MDS) (1)